The Medical Letter on Drugs and Therapeutics
January 10, 1992
|Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article.|
January 10, 1992 (Issue: 861)Disodium pamidronate (Aredia - Ciba-Geigy), an aminohydroxypropilidene bisphosphonate, has been approved by the US Food and Drug Administration for intravenous (IV) treatment of hypercalcemia associated with malignancy, with or without bone...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.